Full course description
Comprehensive Contraceptive Education:
SB 513 SD1 HD1 authorizes pharmacists to prescribe and dispense self-administered hormonal contraceptive supplies to patients regardless of a previous prescription, subject to specified education and procedural requirements. Authorizes insurance reimbursement to pharmacists. The first such statewide protocol is self-administered contraception.
Hawaii was the fourth state in the nation to allow pharmacists to prescribe contraceptives. The Hawaii statute provides this per protocol. Additional materials, including self-screening questionnaires, treatment algorithm, and current contraceptive guidelines are available on the Hawaii State Board of Pharmacy website.
Women in the United States have had access to highly effective hormonal contraception in the form of an oral pill for decades. However, they have always needed to see their doctor or women’s health provider in order to get a prescription for it, causing what many believe to be an unnecessary hurdle. The American Congress of Obstetricians and Gynecologists (ACOG) have issued a formal statement that self-administered hormonal contraception should be made more accessible by removing this barrier. This is because the benefit of preventing unintended pregnancies by improving access to hormonal contraception outweighs the small risks associated with serious adverse events.
While pharmacists are knowledgeable in being able to counsel women on the side effects and what to expect, before now they have never been in the role of starting or continuing a woman on any form of hormonal contraception. It is good to have a foundational knowledge on hormonal contraception, but prescribing it requires a deeper understanding of how to practice seeing patients and in making clinical decisions.
This training program has received significant support and guidance from several OBGYN members of ACOG, and is specifically designed to give pharmacists the tools needed to be confident and successful in prescribing and monitoring self-administered hormonal contraception.
This training program has been approved by the Hawaii State Board of Pharmacy as fulfilling the requirements of Chapter 461 of Hawaii's Revised Statutes and is accredited by ACPE.
Accreditation Council for Pharmacy Education Information:
This program has been planned and implemented in accordance with the policies of the Accreditation Council for Pharmacy Education through the sponsorship of OSU College of Pharmacy. The OSU College of Pharmacy is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Upon completion of this activity, participants will receive a Certificate of Completion, and a Statement of Credit shall be uploaded to CPE Monitor. Completion requires 1) Registration for the course 2) Completion of all modules and 3) Completion of the program evaluation.
Activity Type: Application
Activity Release Date: 01/01/2022
Activity Expiration Date: 01/01/2025
About the Course:
The guidelines for contraceptive use put out by the CDC have an app that can be downloaded for use. You can find it by searching "US MEC US SPR" in iTunes or Google Play, or by clicking on this link and scrolling down: US MEC App, the guidelines for contraceptive use put out by the CDC.
An NABP e-Profile ID and NPI number must be provided to complete the registration process, if you need help credentialing please contact the OSU College of Pharmacy.
If you have any questions regarding the course, please contact OSU College of Pharmacy.
If you've already completed one of our ACPE accredited state courses and need certification in an additional state(s), please click here to complete the form request.